International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.2800
+0.0140 (5.26%)
At close: Oct 9, 2026

International Stem Cell Revenue

International Stem Cell had revenue of $2.68M in the quarter ending June 30, 2026, with 9.32% growth. This brings the company's revenue in the last twelve months to $9.51M, up 3.40% year-over-year. In the year 2025, International Stem Cell had annual revenue of $9.10M with 0.17% growth. That makes International Stem Cell the 37,530th largest company in the world by revenue and 4,935th in the United States.

Revenue (ttm)
9.51M
Revenue Growth
+3.40%
P/S Ratio
0.22
Revenue / Employee
288.30K
Employees
33
Market Cap
2.24M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.10M15.00K0.17%
Dec 31, 20249.09M1.30M16.64%
Dec 31, 20237.79M-391.00K-4.78%
Dec 31, 20228.18M1.00M13.99%
Dec 31, 20217.18M48.00K0.67%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CASI Pharmaceuticals20.11M
BioAtla8.50M
Pacific Software2.40M
GPL Holdings376.54K
Enzolytics46.59K
Aditxt14.34K
VitaSpring Biomedical-1.49M
Revenue Rankings